Fecal microbiota transplantation for the treatment of recurrent <i>Clostridioides difficile</i> (<i>Clostridium difficile</i>)-Reference-Cited by-同舟云学术

Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile)

Published:2023-04-25 Issue:4 Volume:2023 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Minkoff Nathan Zev¹,Aslam Scheherzade²,Medina Melissa³,Tanner-Smith Emily E⁴,Zackular Joseph P⁵,Acra Sari⁶,Nicholson Maribeth R⁶,Imdad Aamer⁷

Affiliation:

1. Pediatric Gastroenterology, Hepatology and Nutrition; Valley Children's Hospital; Madera California USA

2. Department of Pediatrics, Division of Pediatric Gastroenterology, Hepatology and Nutrition; University of Nebraska Medical Center; Omaha Nebraska USA

3. Department of Public Health and Preventative Medicine; SUNY Upstate Medical University; Syracuse, New York USA

4. Counseling Psychology and Human Services; University of Oregon; Eugene Oregon USA

5. Department of Pathology and Laboratory Medicine; University of Pennsylvania and Children’s Hospital of Philadelphia; Philadelphia Pennsylvania USA

6. Department of Pediatrics, D. Brent Polk Division of Gastroenterology, Hepatology and Nutrition; Vanderbilt University School of Medicine; Nashville Tennessee USA

7. Department of Pediatrics, Division of Pediatric Gastroenterology, Hepatology and Nutrition; SUNY Upstate Medical University; Syracuse New York USA

Publisher

Wiley

Subject

Pharmacology (medical)

Reference128 articles.

1. Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection;Cammarota;Alimentary Pharmacology and Therapeutics,2015

2. Oral vancomycin followed by fecal transplantation versus tapering oral vancomycin treatment for recurrent Clostridium difficile infection: an open-label, randomized controlled trial;Hota;Clinical Infectious Diseases,2017

3. Fecal microbiota transplantation is superior to fidaxomicin for treatment of recurrent Clostridium difficile infection;Hvas;Gastroenterology,2019

4. Effect of fecal microbiota transplantation on recurrence in multiply recurrent Clostridium difficile infection – a randomized trial;Kelly;Annals of Internal Medicine,2016

5. Complete microbiota engraftment is not essential for recovery from recurrent Clostridium difficile infection following fecal microbiota transplantation;Staley;mBio,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Host Immune Responses to Clostridioides difficile Infection and Potential Novel Therapeutic Approaches;Tropical Medicine and Infectious Disease;2023-11-23

2. Efficacy, Safety, and Concerns on Microbiota Modulation, Antibiotics, Probiotics, and Fecal Microbial Transplant for Inflammatory Bowel Disease and Other Gastrointestinal Conditions: Results from an International Survey;Microorganisms;2023-11-19

3. In immunocompetent people, what are the benefits and harms of fecal microbiota transplantation (FMT) from healthy donors for the treatment of recurrent Clostridium difficile infection?;Cochrane Clinical Answers;2023-06-26